Pacific biosciences of california stock.

Pacific Biosciences of California Inc’s price is currently down 2.39% so far this month. During the month of September, Pacific Biosciences of California Inc’s stock price has reached a high of $11.96 and a low of $10.14. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low as $4.97.Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) gapped up prior to trading on Friday .The stock had previously closed at $6.52, but opened at $6.92. Pacific Biosciences ...The firm now holds 59,626 shares of the biotechnology company’s stock, after selling 59,343 shares in the quarter. According to financial data as of the end of the reporting period, these holdings were valued at $793,000. Pacific Biosciences of California is a renowned biotechnology company that specializes in genetic sequencing …Pacific Biosciences (PACB) Has Made a Bottom Pattern: Prices to Watch...PACB Pacific Biosciences of California Inc. (PACB) is a biotechnology company that develops and manufactures systems for gene sequencing and biological observation. Let...Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q4 2015 Results - Earnings Call Transcript SA Transcripts Wed, Feb. 03, 2016 Pacific Biosciences of California (PACB) Q4 2015 ...

Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq News. PacBio Announces …PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ...

Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock ...

Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.Jan 9, 2023 · Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ... Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.Pacific Biosciences of California, Inc. has a twelve month low of $5.74 and a twelve month high of $14.55. The stock has a market cap of $2.37 billion, a P/E ratio of -6.99 and a beta of 1.78. The ...

Traveling by car offers a sense of freedom and adventure that is hard to replicate with other modes of transportation. The Pacific Coast Highway, also known as Highway 1, stretches for over 600 miles along the stunning coastline of Californ...

Reassessing Pacific Biosciences: Deep Dive Into Q3 2023 Revenue Surge And Market Dynamics 11/20/23-9:07AM EST Seeking Alpha Pacific Biosciences of California rises after UBS upgrades on strong ...

Transcript : Pacific Biosciences of California, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 12:55 PM Sep. 12: CI Pacific Biosciences of California Introduces Program for Customers to Lease its Sequencing Systems Sep. 12: MTGet the latest Pacific Biosciences of California, Inc. (PACB) stock news and headlines to help you in your trading and investing decisions. ... Pacific Biosciences of California, Inc. (NASDAQ:PACB ...Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ...Pacific Biosciences of California (NASDAQ:PACB) rose 3.16% Friday pre-market after UBS upgraded the sequencing systems company on a strong "Revio" demand. ... The stock is currently trading at $7. ...Source: Shutterstock. We wouldn't blame Pacific Biosciences of California, Inc. NASDAQ:PACB) shareholders if they were a little worried about the fact that Christian O. Henry, the President recently netted about US$980k selling shares at an average price of US$10.12. That sale reduced their total holding by 29% which is hardly …Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.Pacific Biosciences of California Inc’s price is currently up 8.37% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.52. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.

View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ. ٠٧‏/٠٨‏/٢٠٢٣ ... 9/13/2023 Pacific Biosciences CA sees its Relative Strength Rating reach the... Pacific Biosciences of California Stock Clears Key Benchmark, ...The stock price of Pacific Biosciences of California, a biotechnology company that develops gene sequencing systems, has seen a large fall of 38% over the …Pacific Biosciences of California Stock Performance. PACB stock opened at $8.88 on Friday. The business’s 50-day moving average price is $7.76 and its two-hundred day moving average price is $10.63.Currently, the analyst consensus on Pacific Biosciences is a Hold with an average price target of $11.40. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $14.20 and a ...

A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. ... Pacific Biosciences of California rises after UBS upgrades on strong 'Revio ...During the last session, Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares were 3.39 million, with the beta value of the company hitting 1.79. At the end of the trading day, the stock’s price was $8.48, reflecting an intraday loss of -3.53% or -$0.31. The 52-week high for the ...

Pacific Biosciences Of California reported $68.26M in Stock for its fiscal quarter ending in September of 2023. Data for Pacific Biosciences Of California ...Transcript : Pacific Biosciences of California, Inc. Presents at UBS MedTech, Tools and Genomics Summit 2023, Aug-16-2023 04:00 PM Aug. 16: CI Pacific Biosciences of California, GeneDx Partner With University of Washington to Study Long-Read Sequencing Aug. 07: MT9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ...SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific …Dec 1, 2023 · The Pacific Biosciences of California stock price gained 4.72% on the last trading day (Friday, 1st Dec 2023), rising from $8.48 to $8.88. During the last trading day the stock fluctuated 8.77% from a day low at $8.21 to a day high of $8.93. The price has risen in 7 of the last 10 days and is up by 17% over the past 2 weeks. Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares stood at 3.89 million during the last session, with the company’s beta value hitting 1.76. At the close of trading, the stock’s price was $8.36, to imply an increase of 0.97% or $0.08 in intraday trading.PDF Version. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a 30-day option to purchase up to an ...Pacific Biosciences of California (PACB): Stock Market Performance, Earnings Growth, and Market Analysis. On June 30, 2023, Pacific Biosciences of California (PACB) had a mixed performance in the stock market. The stock opened at $13.77 and fluctuated between $13.59 and $14.07 throughout the day. The trading …

See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

As of Tuesday, October 31, Pacific Biosciences of California Inc’s PACB share price has dipped by 13.08%, which has investors questioning if this is right time to buy. Premium Products ... Stock Superstars Report Get stock ideas inspired by the market's leading professionals; VMQ Stocks For the ...

HENRY CHRISTIAN O, the of Pacific Biosciences of California Inc, sale 96,844 shares at $10.12 during a trade that took place back on Sep 18, which means that HENRY CHRISTIAN O is holding 1,106,095 shares at $980,255 based on the most recent closing price. Stock Fundamentals for PACB. Current profitability levels for the company …Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [failed verification] PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the …Pacific Biosciences of California Inc’s price is currently up 8.37% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.52. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. ... Pacific Biosciences of California rises after UBS upgrades on strong 'Revio ...Pacific Biosciences of California, Inc. (PACB) latest earnings report: revenue, EPS, surprise, history, news and analysis.Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Wall Street Stock Market & Finance report, prediction for the future: You'll find the Pacific Biosciences of California share forecasts, stock quote and buy / sell signals below. According to present data Pacific Biosciences of California's PACB shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Pacific Biosciences of California, Inc. 1305 O’Brien Drive Menlo Park, CA 94025 United States 650 521 8000 https://www.pacb.com Sector(s) : Healthcare Industry : Medical Devices Full Time ...MENLO PARK, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September 28, …

Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock …٢٠‏/١١‏/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Pacific Biosciences of California share forecasts, stock quote and buy / sell signals below. According to present data Pacific Biosciences of California's PACB shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Instagram:https://instagram. best motorcycle insurance in texasazo dollar generalewq stockopera singer bocelli Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. prrxxera stock MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 … which sector to invest now Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Pacific Biosciences (PACB) Has Made a Bottom Pattern: Prices to Watch...PACB Pacific Biosciences of California Inc. (PACB) is a biotechnology company that develops and manufactures systems for gene sequencing and biological observation. Let...Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock at $16.44, your return over the last 13 years would have been -47.99%, for an annualized return of -4.9% (not including any dividends or dividend reinvestments).